ECB-IBS 2022 (European Congress on Biotechnology, Maastricht)
On behalf of the Dutch Biotechnology Association (NBV), we warmly welcome you to participate in this major world Biotechnology Congress in the beautiful city of Maastricht, the Netherlands. This will be a joint Congress, IBS2022 and ECB2022. The annual Netherlands Biotechnology Conference, NBC-22, as well as other highlight and satellite events from partners will complete the program. Since 1960, IBS2022 has been the major event organised by the biotechnology sub-division of IUPAC, the International Union of Pure and Applied Chemistry. ECB2022 is the 19th Congress organised by the European Federation of Biotechnology.
Though small in surface area, the Netherlands is a major player in biotechnology. Its success is based on a strong academic backbone, an entrepreneurial spirit, a remarkable talent to get things organized and a natural ability to cooperate. Maastricht lies at the heart of a region of 4 million people from four countries. It is the oldest city of the Netherlands and has maintained its epic charm. It is relatively small and compact with about 125.000 inhabitants. The city has an important international focus, with many international institutes, an academic hospital, a university, and the renowned conference centre MECC. Another advantage of this central location is the direct access to neighbouring biotechnology activities in Belgium, Germany and France.
IBS2022, ECB2022 and NBC-22 will showcase frontline science that will form the basis for future commercial innovation. The scientific programme reveals an excellent line-up of plenary lectures and invited speakers. In line with the IBS and ECB tradition, we will promote the participation of young scientists by encouraging them to submit their original work to be considered for presentation as short talks or posters.
Looking forward to meeting you in Maastricht!
Richard van Kranenburg & Aldrik Velders